Format
Sort by
Items per page

Send to

Choose Destination

Best matches for treatment irritable bowel syndrome:

Irritable bowel syndrome: pathogenesis, diagnosis, treatment, and evidence-based medicine. Saha L et al. World J Gastroenterol. (2014)

Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysis. Didari T et al. World J Gastroenterol. (2015)

Irritable bowel syndrome: a concise review of current treatment concepts. Wall GC et al. World J Gastroenterol. (2014)

Search results

Items: 1 to 20 of 6600

1.

Therapeutic Potential of Zataria multiflora Boiss in Treatment of Irritable Bowel Syndrome (IBS).

Mahboubi M.

J Diet Suppl. 2018 Jan 15:1-10. doi: 10.1080/19390211.2017.1409852. [Epub ahead of print]

PMID:
29333891
2.

Pilot-RCT of an integrative group therapy for patients with refractory irritable bowel syndrome (ISRCTN02977330).

Berens S, Stroe-Kunold E, Kraus F, Tesarz J, Gauss A, Niesler B, Herzog W, Schaefert R.

J Psychosom Res. 2018 Feb;105:72-79. doi: 10.1016/j.jpsychores.2017.12.002. Epub 2017 Dec 5.

PMID:
29332637
3.

Clostridium butyricum regulates visceral hypersensitivity of irritable bowel syndrome by inhibiting colonic mucous low grade inflammation through its action on NLRP6.

Zhao K, Yu L, Wang X, He Y, Lu B.

Acta Biochim Biophys Sin (Shanghai). 2018 Jan 10. doi: 10.1093/abbs/gmx138. [Epub ahead of print]

PMID:
29329362
4.

Gastroenterology today: between certainties and news: a meeting held in Turin on May 27, 2017.

Pellicano R, Ribaldone DG, Astegiano M, Dughera L, Battaglia E, Morgando A, Arrigoni A, Spandre M, Grassini M, Saracco GM, Mégraud F.

Minerva Gastroenterol Dietol. 2018 Jan 10. doi: 10.23736/S1121-421X.18.02465-0. [Epub ahead of print]

PMID:
29327820
5.

The therapeutic effects of Cannabis and cannabinoids: An update from the National Academies of Sciences, Engineering and Medicine report.

Abrams DI.

Eur J Intern Med. 2018 Jan 8. pii: S0953-6205(18)30003-7. doi: 10.1016/j.ejim.2018.01.003. [Epub ahead of print] Review.

PMID:
29325791
6.

Diagnosis and Treatment of Chronic Fatigue Syndrome/Myalgic Encephalopathy (CFS/ME) [Internet].

Bruun Wyller V, Bjørneklett A, Brubakk O, Festvåg L, Follestad I, Malt U, Malterud K, Nyland H, Rambøl H, Stubhaug B, Larun L.

Oslo, Norway: Knowledge Centre for the Health Services at The Norwegian Institute of Public Health (NIPH); 2006.

7.

Laypersons Knowledge and Perceptions of Irritable Bowel Syndrome as Potential Barriers to Care.

Sherwin LB.

J Adv Nurs. 2018 Jan 10. doi: 10.1111/jan.13521. [Epub ahead of print]

PMID:
29319900
8.

Linaclotide in Irritable Bowel Syndrome with Constipation: A Phase 3 Randomized Trial in China and Other Regions.

Yang Y, Fang J, Guo X, Dai N, Shen X, Yang Y, Sun J, Bhandari BR, Reasner DS, Cronin JA, Currie MG, Johnston JM, Zeng P, Montreewasuwat N, Chen GZ, Lim S.

J Gastroenterol Hepatol. 2018 Jan 10. doi: 10.1111/jgh.14086. [Epub ahead of print]

PMID:
29319191
9.

Ramosetron for the treatment of irritable bowel syndrome with diarrhea: a systematic review and meta-analysis of randomized controlled trials.

Qi Q, Zhang Y, Chen F, Zuo X, Li Y.

BMC Gastroenterol. 2018 Jan 8;18(1):5. doi: 10.1186/s12876-017-0734-2.

10.

Management of Functional Somatic Syndromes and Bodily Distress.

Henningsen P, Zipfel S, Sattel H, Creed F.

Psychother Psychosom. 2018 Jan 6;87(1):12-31. doi: 10.1159/000484413. [Epub ahead of print]

PMID:
29306954
12.

Experimental Models of Irritable Bowel Syndrome and the Role of the Enteric Neurotransmission.

Vannucchi MG, Evangelista S.

J Clin Med. 2018 Jan 3;7(1). pii: E4. doi: 10.3390/jcm7010004. Review.

13.

Fecal microbiota transplantation as a possible treatment of irritable bowel syndrome.

Juncadella AC, Moss A.

Ann Transl Med. 2017 Dec;5(24):506. doi: 10.21037/atm.2017.09.13. No abstract available.

14.

Gut dysbiosis and irritable bowel syndrome: The potential role of probiotics.

Principi N, Cozzali R, Farinelli E, Brusaferro A, Esposito S.

J Infect. 2017 Dec 29. pii: S0163-4453(17)30412-7. doi: 10.1016/j.jinf.2017.12.013. [Epub ahead of print] Review.

PMID:
29291933
15.

Bifidobacterium longum and Lactobacillus helveticus Synergistically Suppress Stress-related Visceral Hypersensitivity Through Hypothalamic-Pituitary-Adrenal Axis Modulation.

Ait-Belgnaoui A, Payard I, Rolland C, Harkat C, Braniste V, Théodorou V, Tompkins TA.

J Neurogastroenterol Motil. 2018 Jan 30;24(1):138-146. doi: 10.5056/jnm16167.

16.

Sexual Abuse Is Associated With an Abnormal Psychological Profile and Sleep Difficulty in Patients With Irritable Bowel Syndrome in Taiwan.

Lee HF, Liu PY, Wang YP, Tsai CF, Chang FY, Lu CL.

J Neurogastroenterol Motil. 2018 Jan 30;24(1):79-86. doi: 10.5056/jnm17004.

17.

Functional Bowel Disorders: A Roadmap to Guide the Next Generation of Research.

Chang L, Di Lorenzo C, Farrugia G, Hamilton FA, Mawe GM, Pasricha PJ, Wiley JW.

Gastroenterology. 2017 Dec 27. pii: S0016-5085(17)36714-8. doi: 10.1053/j.gastro.2017.12.010. [Epub ahead of print]

PMID:
29288656
18.

Anxiety and Depression in Irritable Bowel Syndrome.

Banerjee A, Sarkhel S, Sarkar R, Dhali GK.

Indian J Psychol Med. 2017 Nov-Dec;39(6):741-745. doi: 10.4103/IJPSYM.IJPSYM_46_17.

19.

Efficacy and safety of serotonin receptor ligands in the treatment of irritable bowel syndrome: a review.

Binienda A, Storr M, Fichna J, Salaga M.

Curr Drug Targets. 2017 Dec 27. doi: 10.2174/1389450119666171227225408. [Epub ahead of print]

PMID:
29284389
20.

[Update of the Rome IIII( criteria for functional constipation].

Yu T, Jiang L, Lin L.

Zhonghua Wei Chang Wai Ke Za Zhi. 2017 Dec 25;20(12):1334-1338. Chinese.

PMID:
29280110

Supplemental Content

Loading ...
Support Center